APENApollo Endosurgery, Inc.

Nasdaq apolloendo.com


$ 9.99 $ 0.08 (0.81 %)    

Monday, 03-Apr-2023 15:54:51 EDT
QQQ $ 441.71 $ -1.21 (-0.27 %)
DIA $ 395.04 $ 1.04 (0.26 %)
SPY $ 520.76 $ 0.59 (0.11 %)
TLT $ 90.14 $ -0.49 (-0.54 %)
GLD $ 218.73 $ 1.78 (0.82 %)
$ 10
$ 9.93
$ -214,748.36 x 0
$ 0.00 x 0
$ 9.92 - $ 10.00
$ 3.49 - $ 10.30
1,658,846
na
406.5M
$ 0.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-30-2023 12-31-2022 10-K
2 11-01-2022 09-30-2022 10-Q
3 08-02-2022 06-30-2022 10-Q
4 05-03-2022 03-31-2022 10-Q
5 02-22-2022 12-31-2021 10-K
6 11-01-2021 09-30-2021 10-Q
7 08-03-2021 06-30-2021 10-Q
8 05-04-2021 03-31-2021 10-Q
9 02-25-2021 12-31-2020 10-K
10 11-05-2020 09-30-2020 10-Q
11 08-04-2020 06-30-2020 10-Q
12 05-04-2020 03-31-2020 10-Q
13 03-26-2020 12-31-2019 10-K
14 10-30-2019 09-30-2019 10-Q
15 07-24-2019 06-30-2019 10-Q
16 05-02-2019 03-31-2019 10-Q
17 03-18-2019 12-31-2018 10-K
18 11-08-2018 09-30-2018 10-Q
19 08-08-2018 06-30-2018 10-Q
20 05-03-2018 03-31-2018 10-Q
21 03-01-2018 12-31-2017 10-K
22 10-26-2017 09-30-2017 10-Q
23 08-01-2017 06-30-2017 10-Q
24 05-04-2017 03-31-2017 10-Q
25 03-24-2017 12-31-2016 10-K
26 11-10-2016 09-30-2016 10-Q
27 08-09-2016 06-30-2016 10-Q
28 05-10-2016 03-31-2016 10-Q
29 03-22-2016 12-31-2015 10-K
30 11-12-2015 09-30-2015 10-Q
31 08-11-2015 06-30-2015 10-Q
32 05-08-2015 03-31-2015 10-Q
33 03-24-2015 12-31-2014 10-K
34 11-12-2014 09-30-2014 10-Q
35 08-08-2014 06-30-2014 10-Q
36 05-09-2014 03-31-2014 10-Q
37 03-18-2014 12-31-2013 10-K
38 11-08-2013 09-30-2013 10-Q
39 08-14-2013 06-30-2013 10-Q
40 05-07-2013 03-31-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cowen--co-downgrades-apollo-endosurgery-to-market-perform-lowers-price-target-to-10

Cowen & Co. analyst Joshua Jennings downgrades Apollo Endosurgery (NASDAQ:APEN) from Outperform to Market Perform and lo...

 analyzing-apollo-endosurgerys-short-interest

Apollo Endosurgery's (NASDAQ:APEN) short percent of float has fallen 63.08% since its last report. The company recently rep...

 stifel-downgrades-apollo-endosurgery-to-hold-announces-10-price-target

Stifel analyst Mathew Blackman downgrades Apollo Endosurgery (NASDAQ:APEN) from Buy to Hold and announces $10 price target.

 10-best-stock-traders-in-congress-in-2022-spoiler-nancy-pelosi-isnt-no-1

A new report was out about the performance of members of the U.S. Congress who bought and sold stocks and options in 2022. The...

 apollo-endosurgery-announces-american-society-for-metabolic-and-bariatric-surgery-added-apollo-systems-to-list-of-fda-approved-bariatric-devices-on-december-5

Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointe...

 lake-street-downgrades-apollo-endosurgery-to-hold-lowers-price-target-to-10

Lake Street analyst Frank Takkinen downgrades Apollo Endosurgery (NASDAQ:APEN) from Buy to Hold and lowers the price target ...

 nasdaq-down-50-points-crude-oil-rises-over-1

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 50 points on Tuesday.

 us-stocks-turn-lower-dow-falls-over-100-points

U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday.

 why-shares-of-chinese-companies-are-trading-higher-here-are-45-stocks-moving-in-tuesdays-mid-day-session

Gainers Otonomy, Inc. (NASDAQ: OTIC) shares surged 74.2% to $0.1866. Otonomy recently posted a Q3 loss of $0.18 per share.

 us-stocks-edge-higher-following-mondays-sell-off

U.S. stocks traded slightly higher this morning, with the Dow Jones gaining more than 30 points on Tuesday. The blue-chip index...

 earnings-scheduled-for-november-1-2022

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION